REGN vs THFF · P/E 14, rev $14.34B vs P/E 11, $866.7M cap
Regeneron Pharmaceuticals Inc (REGN) versus First Financial Corporation Indiana (THFF) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
First Financial Corporation Indiana (THFF) is a banks - regional company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
THFF does not have a complete income-statement cache yet.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. THFF currently screens at market cap $866.7M and trailing P/E 10.7.
Not investment advice. Open the REGN and THFF stock pages for the full models.
Not investment advice.